Effects of oxygen therapy on systemic inflammation and myeloperoxidase modified LDL in hypoxemic COPD patients
To access this article, please choose from the options below
PII: S0021-9150(09)00075-6
doi:10.1016/j.atherosclerosis.2009.01.028
© 2009 Published by Elsevier Inc.
